Omega-3 fatty acids help reduce lung inflammation caused by dust exposure
Omega-3 fatty acids induce macrophage IL-22 signaling to promote resolution of dust-induced lung inflammation
This study is looking at how omega-3 fatty acids might help your lungs recover from inflammation caused by breathing in dust, focusing on a special substance called maresin-1 that could boost your lung health and protect your airways.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Colorado State University NIH-funded |
| Lab location | 1 site (Fort Collins, United States) |
| Project ID | NIH-11128434 on NIH RePORTER |
What this research studies
This research investigates how omega-3 fatty acids can activate specific signaling pathways in lung macrophages to help resolve inflammation caused by inhaling dust from various environments. The study focuses on understanding the role of a lipid mediator derived from omega-3s, known as maresin-1, and its ability to enhance mucosal immunity and maintain the integrity of the airway epithelium. By examining the effects of these fatty acids on lung health, the research aims to uncover potential protective mechanisms against airway diseases linked to dust exposure.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced chronic exposure to dust, particularly those living in urban, rural, or farming environments.
Not a fit: Patients who do not have a history of dust exposure or existing lung conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new dietary recommendations or treatments that utilize omega-3 fatty acids to improve lung health and reduce inflammation in individuals exposed to harmful dust.
How similar studies have performed: Previous research has shown promising results regarding the protective effects of omega-3 fatty acids on lung health, suggesting that this approach may be effective.
Where this research is happening
Fort Collins, United States
- Colorado State University — Fort Collins, United States (Active)
Researchers
- Principal investigator: Nordgren, Tara M — Colorado State University
- Study coordinator: Nordgren, Tara M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.